Preventing pressure injuries in hospitalized infants, children, and young people (0–19 years) with darker skin tones
Official title: Prevention of Pressure Injury (PI) in Hospitalised Infants, Children, and Young People (CYP) (Aged 0-19 Years)
Run by Nottingham University Hospitals NHS Trust · NCT07303569 · Data updated 2026-11-12
This project will test whether a modified BRADEN-QD tool better identifies pressure injury risk in hospitalized infants, children, and young people with darker skin tones.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 542 (estimated) |
| Sponsor | Nottingham University Hospitals NHS Trust Academic / other |
| Locations | 1 site (Nottingham) |
| Status | Recruiting |
| Started | July 30, 2025 |
| Main results expected | May 16, 2026 |
| Study ends | May 16, 2026 |
| Registry record updated | December 26, 2025 |
| Trial ID | NCT07303569 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are hospitalized infants, children, and young people aged 0–19 years with darker skin tones (typically Fitzpatrick types IV–VI) who are admitted for at least 24 hours and are at risk of or have developed pressure injuries.
✕Probably not a fit
Patients without darker skin tones, those not hospitalized at participating sites, or individuals with advanced, already-established pressure injuries unlikely to be preventable may not benefit from this prevention-focused work.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This mixed-methods program first gathers input from clinicians, parents, and older children through interviews and online workshops to identify additional pressure-injury risk items relevant to darker skin tones, using a nominal group technique and a modified Delphi process with ≥70% consensus to create a modified BRADEN-QD (mBRADEN-QD). In phase two the original and/or modified BRADEN-QD will undergo multicentre psychometric validation in hospitalized infants and children with darker skin (Fitzpatrick types IV–VI). Data collection includes qualitative interviews, ranked item consensus, and prospective bedside assessments across participating centres. The goal is to determine whether the tool needs modification and to validate its accuracy for detecting pressure injury risk in this population.
Why it matters
Potential benefit: If successful, the modified tool could help clinicians identify pressure injury risk earlier in children with darker skin tones, reducing sores, treatments, and related distress for families.
How similar studies have gone: Existing risk-assessment tools for pressure injury exist, but few have been specifically validated or modified for children with darker skin tones, so this work addresses a largely untested gap.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Phase 1 HCP participants: 1. Experts (e.g. tissue viability practitioners, dermatologist) 2. HCP looking after hospitalised infants and CYP 3. Able to give consent Parent/ guardian participants: 1. Parents/ guardians of infants and CYP admitted to hospital with or developed PI 2. Parent/ guardian of a CYP under 19 years of age with dark skin tone according to Fitzpatrick Classification of Skin Types III, IV, V or VI. 3. Able to give consent CYP participants: 1. Age 10 - 19 2. Dark skin tone according to Fitzpatrick Classification of Skin Types III, IV, V or VI. 3. Able to gain consent 4. Able to provide assent with parental consent 5. Developed PI during hospitalisation Phase 2 Hospitalised infants and CYP participants 1\. Infants and CYP admitted to hospital for 24 hrs 2. Age 0-19 years 3. Able to gain consent. 4. Fitzpatrick Classification of Skin Types IV, V or VI. Exclusion Criteria: Phase1: HCP participants: 1. HCP not working with hospitalised infants and CYP. 2. Unable to provide consent. Parents participants: 1. Parents of hospitalised infants and CYP with no PI. 2. Unable to gain consent CYP participants: 1. Not able to provide consent 2. CYP with no PI during hospitalisation period Phase 2 1\. Admitted to hospital for less than 24 hrs 2. Unable to gain consent 3. Fitzpatrick Classification of Skin Types I, II or III
Where it's running
-
Nottingham University Hospital
Nottingham, United Kingdom Recruiting
Study contacts
- Principal investigator: Takawira C Marufu, Phd — Nottingham University Hospital
- Study coordinator: Kathleen Holding, PhD
- Email: Kathleen.Holding@nhs.net
- Phone: +44 115 92499240 ext. 83746
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tocotrienol-loaded Dressing for Stage 1–2 Pressure Ulcers
Atocotrienol-containing wound dressing is being tested to see if it helps heal stage 1–2 pressure ulcers better than standard dressings.
-
Gamified metaverse training to teach nursing students pressure ulcer care
This project tests whether a gamified metaverse training helps second-year nursing students feel more confident and learn to prevent and manage pressure ulcers.
-
Interactive e-book training to improve home care nurses' pressure injury care
This project will test whether an interactive online e-book helps home care nurses learn more and feel more confident when preventing and treating pressure injuries.
-
Adhesive versus elastic leg devices to secure urinary catheters in critically ill adults
This trial will test whether adhesive or elastic leg securement devices better prevent meatal injuries, reduce discomfort, and lower catheter-associated urinary tract infections in critically ill adults with urinary catheters.
-
Community-based care bundle to treat and prevent pressure injuries at home
This program will try a home-based pressure injury care bundle to help older adults discharged home and their caregivers heal existing sores and prevent new ones.
-
Effects of Physical Therapy on Wound Healing in Spinal Cord Injury Patients
This study is testing whether different types of physical therapy can help improve wound healing in people with spinal cord injuries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.